PIPELINE

MORE
(Califia) A San Diego based company developing novel Transcription-Coupled Repair I..
EUPHOL, INGENOL B AND INGENOL C
(U of Warwick) Glyoxalase 1 Inducers: First-In-Class Treatment for Diabetic Renal D..
(U of Oxford) Superior dendritic cells for immunotherapy
(U of Liverpool) Novel Recombinant Protein Therapeutic for Castration-Resistant Pro..
(U of Liverpool) CD40L TRAIL fusion protein induces cell death in DR4- and DR5- pos..
(U of Helsinki) Oncolytic adenoviruses coated with MHC-I tumor epitopes increase th..
(U of Barcelona) Orally bioavailable, new target-modulating small molecules for the..
(Technical University Munich) Glypican-3-specific T-cell receptor and its uses for ..

GLOBAL C&D PROJECT PARTICIPANTS




    • Aagami
    • Bionaturis
    • Allovate
    • Cellmid
    • Amorchem
    • Crossbeta Biosciences
    • Aurigene
    • Intrommune Therapeutics
    • Kissei Pharmaceutical
    • MyeloRx
    • Genefrontier
    • Coarebiotech
    • Immune Biosolutions
    • NEOMED
    • APIM Therapeutics
    • Ulster University
    • Southern Research
    • UCL
    • Atrin Pharmaceuticals
    • LTTO
    • AVEO Pharmaceuticals
    • ULB
    • Amunix
    • University of Namur
    • iVeena
    • Valin Technologies
    • MBM Sciencebridge
    • Wiborg
    • Aronora, Inc.
    • Lipopharma
    • Aeterna Zentaris
    • cancer research technology
    • yissum
    • yeda